Epigenetic alterations in stem cell ageing-a promising target for age-reversing 
interventions?

Pouikli, A.; Tessarz, P.

doi:10.1093/bfgp/elab010

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Epigenetic alterations in stem cell ageing-a promising target for age-reversing interventions?

MPS-Authors

/persons/resource/persons278096

Pouikli, A.
Tessarz – Chromatin and Ageing, Max Planck Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

/persons/resource/persons277960

Tessarz, P.
Tessarz – Chromatin and Ageing, Max Planck Research Groups, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pubmed/33738480
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Pouikli, A., & Tessarz, P. (2021). Epigenetic alterations in stem cell ageing-a promising target for age-reversing interventions? Brief Funct Genomics, 1(21), 35-42. doi:10.1093/bfgp/elab010.

Cite as: https://hdl.handle.net/21.11116/0000-000A-FAE2-D

Abstract

Ageing is accompanied by loss of tissue integrity and organismal homeostasis partly due to decline in stem cell function. The age-associated decrease in stem cell abundance and activity is often referred to as stem cell exhaustion and is considered one major hallmark of ageing. Importantly, stem cell proliferation and differentiation potential are tightly coupled to the cellular epigenetic state. Thus, research during the last years has started to investigate how the epigenome regulates stem cell function upon ageing. Here, we summarize the role of epigenetic regulation in stem cell fate decisions and we review the impact of age-related changes of the epigenome on stem cell activity. Finally, we discuss how targeted interventions on the epigenetic landscape might delay ageing and extend health-span.